The rapidly evolving treatment for advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinomas, with new biomarkers, therapies, and clinical trial data, has changed care standards. This webinar will help you understand these changes, focusing on biomarker testing, frontline therapy, and toxicity management. Through case challenges and live polling, you'll apply the latest evidence to improve patient care. Sign up today!